Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Why not more
View:
Post by PWIB123 on Feb 06, 2024 9:57am

Why not more

I saw THTX's earnings call and business update announcement this morning, and they only included a special statement about providing clarification and additional details around the CRL?  They set zero expectation for any announcements regarding TH-1902.

I know palinc2000 was expecting market making news on this call.  Has anyone heard anything about TH-1902?  It would appear they are going to skip over TH-1902 again on this conference call.  Maybe they just didn't highlight it like the CRL, but there's been no news after announcing all locations were actively recruiting.
Comment by palinc2000 on Feb 06, 2024 10:37am
I think you are referring to the post below..At that time I was expecting a full FDA approval for F8 which  is a pre requisite to start the  Nash Trial with a partner .... I have expectations for  THTX meetiing the  revenue guidance but the delay in F8 will not give rise to increased optimism for Egrifta sales increase .... TH1902 ? I have no expectations since we dont know ...more  
Comment by Trogarzon on Feb 06, 2024 10:49am
My hope is that Soleus steps up to the plate and impose a strateggic reviw of Thera's operation trough a sale or a merge or major changes at the BOD.
Comment by stockman75 on Feb 06, 2024 8:32pm
This company is like a terd swirling down a flushed toilet... 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities